ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ALLO vs TECX // RSI-14 & 200D SMA MOMENTUM

Allogene Therapeutics Inc. (NASDAQ) VS. Tectonic Therapeutic Inc. (NASDAQ) • 15-METRIC TALLY: ALLO 2 — TECX 1
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TECX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALLO VS. TECX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ALLO TECX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -15.04% — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 ALLO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 33.4 33.9 -0.50 TECX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $407.7M $386.7M $21.0M ALLO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ALLO REV TECX REV ALLO GROSS % TECX GROSS % ALLO FCF TECX FCF
FY 2025 $0 $0 — — -$149.6M -$60.3M
FY 2024 $22.0K $0 — — -$201.0M -$59.2M
FY 2023 $95.0K $0 — — -$237.7M -$40.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALLO // BETA —
TECX // BETA —